These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 31720873)

  • 1. Mitotic checkpoint kinase Mps1/TTK predicts prognosis of colon cancer patients and regulates tumor proliferation and differentiation via PKCα/ERK1/2 and PI3K/Akt pathway.
    Zhang L; Jiang B; Zhu N; Tao M; Jun Y; Chen X; Wang Q; Luo C
    Med Oncol; 2019 Nov; 37(1):5. PubMed ID: 31720873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TTK regulates proliferation and apoptosis of gastric cancer cells through the Akt-mTOR pathway.
    Huang H; Yang Y; Zhang W; Liu X; Yang G
    FEBS Open Bio; 2020 Aug; 10(8):1542-1549. PubMed ID: 32530571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of tyrosine and threonine protein kinase in carcinogenic process of colorectal cancer and its relationship with prognosis].
    Zhang XL; Han WX; Ma YM; Baohan HW; Zhao XH; Wang HY
    Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):172-177. PubMed ID: 28316214
    [No Abstract]   [Full Text] [Related]  

  • 4. TTK activates Akt and promotes proliferation and migration of hepatocellular carcinoma cells.
    Liu X; Liao W; Yuan Q; Ou Y; Huang J
    Oncotarget; 2015 Oct; 6(33):34309-20. PubMed ID: 26418879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of cell apoptosis and proliferation in pancreatic cancer through PI3K/Akt pathway via Polo-like kinase 1.
    Mao Y; Xi L; Li Q; Cai Z; Lai Y; Zhang X; Yu C
    Oncol Rep; 2016 Jul; 36(1):49-56. PubMed ID: 27220401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TTK is a potential therapeutic target for cisplatin-resistant ovarian cancer.
    Liu Y; Zhu K; Guan X; Xie S; Wang Y; Tong Y; Guo L; Zheng H; Lu R
    J Ovarian Res; 2021 Oct; 14(1):128. PubMed ID: 34598710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-218 inhibits the invasion and migration of colon cancer cells by targeting the PI3K/Akt/mTOR signaling pathway.
    Zhang X; Shi H; Tang H; Fang Z; Wang J; Cui S
    Int J Mol Med; 2015 May; 35(5):1301-8. PubMed ID: 25760926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Threonine and tyrosine kinase may serve as a prognostic biomarker for gallbladder cancer.
    Xie Y; Lin JZ; Wang AQ; Xu WY; Long JY; Luo YF; Shi J; Liang ZY; Sang XT; Zhao HT
    World J Gastroenterol; 2017 Aug; 23(31):5787-5797. PubMed ID: 28883705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing TTK expression inhibits the proliferation and progression of prostate cancer.
    Chen S; Wang J; Wang L; Peng H; Xiao L; Li C; Lin D; Yang K
    Exp Cell Res; 2019 Dec; 385(1):111669. PubMed ID: 31605696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Key role of dual specificity kinase TTK in proliferation and survival of pancreatic cancer cells.
    Kaistha BP; Honstein T; Müller V; Bielak S; Sauer M; Kreider R; Fassan M; Scarpa A; Schmees C; Volkmer H; Gress TM; Buchholz M
    Br J Cancer; 2014 Oct; 111(9):1780-7. PubMed ID: 25137017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLF/miR-132/TTK axis regulates cell proliferation, metastasis and radiosensitivity of glioma cells.
    Chen S; Wang Y; Ni C; Meng G; Sheng X
    Biomed Pharmacother; 2016 Oct; 83():898-904. PubMed ID: 27522003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
    Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
    Gene; 2019 May; 698():50-60. PubMed ID: 30822475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of phospholipaseD2 increases hypoxia-induced human colon cancer cell apoptosis through inactivating of the PI3K/AKT signaling pathway.
    Liu M; Fu Z; Wu X; Du K; Zhang S; Zeng L
    Tumour Biol; 2016 May; 37(5):6155-68. PubMed ID: 26614430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated urokinase-type plasminogen activator receptor expression in a colon cancer cell line is due to a constitutively activated extracellular signal-regulated kinase-1-dependent signaling cascade.
    Lengyel E; Wang H; Gum R; Simon C; Wang Y; Boyd D
    Oncogene; 1997 May; 14(21):2563-73. PubMed ID: 9191056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mps1/TTK: a novel target and biomarker for cancer.
    Xie Y; Wang A; Lin J; Wu L; Zhang H; Yang X; Wan X; Miao R; Sang X; Zhao H
    J Drug Target; 2017 Feb; 25(2):112-118. PubMed ID: 27819146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TTK/hMPS1 is an attractive therapeutic target for triple-negative breast cancer.
    Maire V; Baldeyron C; Richardson M; Tesson B; Vincent-Salomon A; Gravier E; Marty-Prouvost B; De Koning L; Rigaill G; Dumont A; Gentien D; Barillot E; Roman-Roman S; Depil S; Cruzalegui F; Pierré A; Tucker GC; Dubois T
    PLoS One; 2013; 8(5):e63712. PubMed ID: 23700430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PKCα in colon cancer cells promotes M1 macrophage polarization via MKK3/6-P38 MAPK pathway.
    Cheng Y; Zhu Y; Xu W; Xu J; Yang M; Chen P; Zhao J; Geng L; Gong S
    Mol Carcinog; 2018 Aug; 57(8):1017-1029. PubMed ID: 29637628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cartilage oligomeric matrix protein is a prognostic factor and biomarker of colon cancer and promotes cell proliferation by activating the Akt pathway.
    Liu TT; Liu XS; Zhang M; Liu XN; Zhu FX; Zhu FM; Ouyang SW; Li SB; Song CL; Sun HM; Lu S; Zhang Y; Lin J; Tang HM; Peng ZH
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1049-1063. PubMed ID: 29560517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TTK predicts triple positive breast cancer prognosis and regulates tumor proliferation and invasion.
    Gao YH; Qu SS; Cao LQ; Yao M
    Neoplasma; 2022 Mar; 69(2):274-282. PubMed ID: 34846157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway.
    Li J; Feng L; Tian C; Tang YL; Tang Y; Hu FQ
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8135-8144. PubMed ID: 30556851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.